C. L. Stokin

TRIM28 and β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers

M. E. Ruaro, S. Muyldermans, H. Motaln, 2014, PloS one.

Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates

A. Buzdin, S. Muyldermans, M. Myers, 2017, Oncotarget.